Concepedia

Sarah Moll

SM

Statistics

Publications

8

Citations

680

H-Index

8

Active since

2002

Affiliations

University College London(Current)

University of Sheffield

Insigneo

Newcastle upon Tyne Hospitals NHS Foundation Trust

University of Cambridge

Sarah Moll is an author at University College London specializing in life sciences, parkinsonian disorders, and placebo-controlled efficacy assessment.

ORCID

Publications per year

2002–2024

8

Publications

8

Formation of Syncytial Knots is Increased by Hyperoxia, Hypoxia and Reactive Oxygen Species

Alexander Heazell, Sarah Moll, Carolyn Jones et al. · Placenta · 2006 · 205 citations

, , +10

Adjunctive rifampicin for Staphylococcus aureus bacteraemia (ARREST): a multicentre, randomised, double-blind, placebo-controlled trial

Guy Thwaites, Matthew Scarborough, Alexander J. Szubert et al. · The Lancet · 2017 · 187 citations · Full text

, , +17

Epidermal growth factor rescues trophoblast apoptosis induced by reactive oxygen species

Sarah Moll, Carolyn Jones, Ian Crocker et al. · APOPTOSIS · 2007 · 76 citations

, , +14

Mobilise-D insights to estimate real-world walking speed in multiple conditions with a wearable device

Cameron Kirk, Arne Küderle, M. Encarna Micó-Amigo et al. · Scientific Reports · 2024 · 71 citations · Full text

, , +16

A Double‐Blind, Randomized, Placebo‐Controlled Trial of Ursodeoxycholic Acid (<scp>UDCA)</scp> in Parkinson's Disease

Thomas Payne, Matthew Appleby, Ellen Buckley et al. · Movement Disorders · 2023 · 64 citations · Full text

, , +17

1–5 of 8